Advances in the adjuvant and neoadjuvant treatment of breast cancer

被引：1

作者：

Briest, Susanne ^{[1
,2
]}

Stearns, Vered ^{[2
]}

机构：

[1] Univ Leipzig, Dept Gynecol & Obstet, Leipzig, Germany

[2] Johns Hopkins Sch Med, Sidney Kimmel Comprehens Canc Ctr, 1650 Orleans St,CRB 1,Room 1M-53, Baltimore, MD 21231 USA

来源：

WOMENS HEALTH | 2007年 / 3卷 / 03期

关键词：

adjuvant treatment; aromatase inhibitors; breast cancer; chemotherapy; hormonal therapy; neoadjuvant treatment; trastuzumab;

D O I：

10.2217/17455057.3.3.325

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Several advances in the adjuvant systemic therapy of primary breast cancer have occurred in the last decade and contributed to a decline in disease-related mortality. These include the introduction of aromatase inhibitors, new chemotherapy agents, and the novel antibody trastuzumab. New supportive treatments, such as growth factors, have contributed to the optimization of chemotherapy dose and schedule, and have improved the efficacy and safety of the treatment. In this review we will outline some of the recent advances in the adjuvant and neoadjuvant treatment of breast cancer. We will also discuss ongoing and proposed clinical trials.

引用

页码：325 / 339

页数：15

共 50 条

[31] Neoadjuvant and adjuvant treatment of pancreatic cancer [J].

Springfeld, C. ;

Hackert, T. ;

Jaeger, D. ;

Buechler, M. W. ;

Neoptolemos, J. P. .

CHIRURG, 2020, 91 (08) :636-641

[32] Controversies in breast cancer: adjuvant and neoadjuvant therapy [J].

Montemurro, F ;

Redana, S ;

Valabrega, G ;

Aglietta, M .

EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (07) :1055-1072

[33] Neoadjuvant or adjuvant chemotherapy in early breast cancer? [J].

Montemurro, Filippo ;

Nuzzolese, Imperia ;

Ponzone, Riccardo .

EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (09) :1071-1082

[34] Curcumin as an Adjuvant to Breast Cancer Treatment [J].

Kumar, Parveen ;

Kadakol, Almesh ;

Shasthrula, Prashanth Krishna ;

Mundhe, Nitin Arunrao ;

Jamdade, Vinayak Sudhir ;

Barua, Chandana C. ;

Gaikwad, Anil Bhanudas .

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2015, 15 (05) :647-656

[35] BREAST-CANCER - THE ADJUVANT TREATMENT [J].

MIGNOT, L .

PATHOLOGIE BIOLOGIE, 1994, 42 (10) :963-964

[36] Adjuvant treatment of breast cancer with taxanes [J].

Wenzel, Catharina ;

Steger, Guenther G. .

BREAST CARE, 2006, 1 (03) :171-175

[37] Adjuvant treatment for breast cancer in the elderly [J].

Marchei, P ;

Bianco, V ;

Pignatelli, E ;

Chiodini, S ;

Santini, D ;

Carico, E ;

Marchei, M ;

Vecchione, A .

ANTICANCER RESEARCH, 1996, 16 (02) :911-913

[38] Neoadjuvant treatment of early breast cancer:: new drugs contribution [J].

Giacchetti, S ;

Cuvier, C ;

Hocini, H ;

Bourstyn, E ;

De Roquancourt, A ;

Espié, M .

BULLETIN DU CANCER, 2004, 91 :S232-S238

[39] Neoadjuvant endocrine treatment in early breast cancer: An overlooked alternative? [J].

van Dam, P. A. ;

van Dam, V. C. N. ;

Altintas, S. ;

Papadimitriou, K. ;

Rolfo, C. ;

Trinh, X. B. .

EJSO, 2016, 42 (03) :333-342

[40] Neoadjuvant therapy for operable breast-cancer [J].

Insa, A ;

Chirivella, I ;

Lluch, A .

MEDICINA CLINICA, 2006, 126 (08) :295-303

← 1 2 3 4 5 →